Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BCC 2025 | The future of patient apps in breast cancer management

Tim Rattay • 13 Mar 2025
BCC 2025
Breast Cancer

Tim Rattay, MBChB, PhD, FRCS, University of Leicester, Leicester, UK, discusses the growing interest of patients in understanding the effects of treatment and their potential long-term outcomes. Developments of patient apps are increasingly being used in practice and trials to provide personalized support and information to patients. Explainable artificial intelligence (AI) can also build trust with clinicians and patients, by providing clear explanations for predictions and risk factors. This interview took place at the 2025 St. Gallen International Breast Cancer Consensus Meeting in Vienna, Austria.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Tim Rattay

Managing radiotherapy induced arm swelling in breast cancer
0:55
Managing radiotherapy induced arm swelling in breast cancer
Tim Rattay • 13 Mar 2025
PRE-ACT-01: AI-based risk prediction for RT-induced lymphoedema
0:45
PRE-ACT-01: AI-based risk prediction for RT-induced lymphoedema
Tim Rattay • 13 Mar 2025
The future of AI in managing breast cancer
1:31
The future of AI in managing breast cancer
Tim Rattay • 18 Mar 2024
Creating an AI prediction model for arm lymphedema in breast cancer
2:56
Creating an AI prediction model for arm lymphedema in breast cancer
Tim Rattay • 18 Mar 2024

Related Videos

How will SARMs fit into the current breast cancer treatment paradigm?
1:14
How will SARMs fit into the current breast cancer treatment paradigm?
Rafael Grochot • 2 Jul 2026
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
1:35
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
Rafael Grochot • 2 Jul 2026
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
1:07
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
Sanjoy Chatterjee • 17 May 2026
Design and aim of the HYPORT study in regional nodal breast cancer
1:23
Design and aim of the HYPORT study in regional nodal breast cancer
Sanjoy Chatterjee • 17 May 2026
The content of VJOncology is intended for healthcare professionals